The AI Maturity Myth
By Matt Wilkinson
The Argonaut's Guide to 12-18 Month Product Roadmaps
By Jasmine Gruia-Gray
AI Can Also Stand for Accelerated Insight
By Matt Wilkinson
Meetings Are Where Roadmaps Go To Die: The Three-Element Meeting Filter
By Jasmine Gruia-Gray
ELRIG Drug Discovery 2025: 68% AI Optimistic, Only 7% Winning
By Matt Wilkinson
Life Science Commercial Blind Spots
By Jasmine Gruia-Gray
AI Isn't the Risk. Waiting Is.
By Matt Wilkinson
Icarus Trap to Launch Ready
By Jasmine Gruia-Gray
While You Ignore AI, Your Competitors Are Training for It
By Matt Wilkinson
Taming the Hydra: Managing Scope Creep in Life Sciences Research Tools
By Jasmine Gruia-Gray